Citation Impact
Citing Papers
Activity-Dependent Internalization of Smoothened Mediated by ß-Arrestin 2 and GRK2
2004 StandoutScienceNobel
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
2011
Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis
2015
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Circulating Tumor DNA as a Liquid Biopsy for Cancer
2014
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
TOR Signaling in Growth and Metabolism
2006 Standout
Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
2008
Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA
2016
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma
1999
Cancer statistics, 2020
2020 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
2002
A view on drug resistance in cancer
2019 StandoutNature
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
2009
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
2007
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
1999
Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines.
1999
Allelic losses on chromosome arm 10q and mutation of the PTEN ( MMAC1 ) tumour suppressor gene in primary and metastatic malignant melanomas
2000
The biology and management of non-small cell lung cancer
2018 StandoutNature
Integrating liquid biopsies into the management of cancer
2017
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
2007
Phosphorylation of Human MAD1 by the BUB1 Kinasein Vitro
1999
BRAFE600-associated senescence-like cell cycle arrest of human naevi
2005 StandoutNature
Lung Cancer
2008 Standout
Fragment Length of Circulating Tumor DNA
2016
Genetic instabilities in human cancers
1998 StandoutNature
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Multiplexed Serum Biomarkers for the Detection of Lung Cancer
2016
Lysyl oxidases: A novel multifunctional amine oxidase family
2001
Levels of Circulating Cell-Free Nuclear and Mitochondrial DNA in Benign and Malignant Ovarian Tumors
2008
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
2007
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
The hedgehog signaling network
2003
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
2007
Microsatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
1999
The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
2017
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
2019
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer
2012
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
2001 StandoutNobel
Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the Perugia Multidisciplinary Team for Thoracic Oncology
2008
Metazoan MicroRNAs
2018 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Circulating Nucleic Acids in Plasma and Serum
2008
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
1998 StandoutNobel
An efficient and sensitive method for preparing cDNA libraries from scarce biological samples
2014 StandoutNobel
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
2007
Circulating miRNAs as Biomarker in Cancer
2019
Epidemiology of Lung Cancer
2013
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
2005
MicroRNAs in body fluids—the mix of hormones and biomarkers
2011
Malignant melanoma: modern black plague and genetic black box
1998
PTEN: Life as a Tumor Suppressor
2001
Polymer-Based Cancer Nanotheranostics: Retrospectives of Multi-Functionalities and Pharmacokinetics
2013
EMT: 2016
2016 Standout
Mutations of the human PTEN gene
2000
PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic β Cells
2008 StandoutNobel
MicroRNAs in Stress Signaling and Human Disease
2012
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Tackling the cancer stem cells — what challenges do they pose?
2014
Blockade of Cd47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma
2014
Circulating nucleic acids (CNAs) and cancer—A survey
2006
The PI3K Pathway in Human Disease
2017 Standout
Circulating tumour‐associated plasma DNA represents an independent and informative predictor of prostate cancer
2006
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
2011
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Clinical Relevance of Circulating Nucleosomes in Cancer
2008
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
2000 StandoutNature
Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy
2008
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma
2006
A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA
2011
Cell‐Surface‐Bound Nucleic Acids: Free and Cell‐Surface‐Bound Nucleic Acids in Blood of Healthy Donors and Breast Cancer Patients
2004
Plasma cell‐free DNA in ovarian cancer
2010
Head and Neck Cancer
2001 Standout
miR-Test: A Blood Test for Lung Cancer Early Detection
2015
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Two-dimensional transition metal dichalcogenide nanomaterials for biosensing applications
2016
Current and Prospective Protein Biomarkers of Lung Cancer
2017
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
2000
The Protein Kinase Complement of the Human Genome
2002 StandoutScience
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Tumor Budding: The Name is EMT. Partial EMT.
2016
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
2002
Deficiency of PTEN in Jurkat T Cells Causes Constitutive Localization of Itk to the Plasma Membrane and Hyperresponsiveness to CD3 Stimulation
2000
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
2004
Somatic mutations of PTEN in glioblastoma multiforme.
1997
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy
2004
Germline PTEN mutations in Cowden syndrome-like families.
1998
Detection and quantification of mutations in the plasma of patients with colorectal tumors
2005
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
1997
Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
2002
Progress and prospects of early detection in lung cancer
2017
Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate Disease
2005
Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
2007
A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization.
2000
Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance
2010
Cohypermethylation of p16 and FHIT Promoters as a Prognostic Factor of Recurrence in Surgically Resected Stage I Non–Small Cell Lung Cancer
2006
Recent Advances in Ultrathin Two-Dimensional Nanomaterials
2017 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Stability of the hybrid epithelial/mesenchymal phenotype
2016
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
2004 Standout
Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue.
2004
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Breast Cancer‐Derived Exosomes Reflect the Cell‐of‐Origin Phenotype
2019
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Works of Luca Roz being referenced
Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
2014
Plasma DNA Quantification in Lung Cancer Computed Tomography Screening
2008
Conversion to stem‐cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells
2015
Detecting lung cancer in plasma with the use of multiple genetic markers
2003
Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas
1997
Identification of PTEN-related sequences in glioma cells and in non-neoplastic cell lines
1999
PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas
1998
Effects of Prolonged Storage of Whole Plasma or Isolated Plasma DNA on the Results of Circulating DNA Quantification Assays
2005
Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.
1996
Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatment
2009
Restoration of fragile histidine triad ( FHIT ) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines
2002
Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis.
1996
Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
2001
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
2003
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
2011